Background
Background Cognitive deficits are a
Cognitive deficits are a core feature of schizophrenia.These core feature of schizophrenia.These deficits are not caused by medication or deficits are not caused by medication or symptoms, and have a dramatic negative symptoms, and have a dramatic negative effect on real-world functioning. effect on real-world functioning.
Aims Aims To critically examine a selection of
To critically examine a selection of the most common batteries used to assess the most common batteries used to assess cognition in schizophrenia. cognition in schizophrenia.
Method Method Literature review of cognitive
Literature review of cognitive assessment batteries for use in assessment batteries for use in schizophrenia. schizophrenia.
Results
Results A wide variety of neuroAwide variety of neurocognitive test batteries have been cognitive test batteries have been developed or adapted to assess cognition developed or adapted to assess cognition in schizophrenia.These differ in time in schizophrenia.These differ in time requirements, repeatability, ease of requirements, repeatability, ease of administrationó degree of face validity, administrationó degree of face validity, availability of co-normative data and availability of co-normative data and degree to which results can be parsed into degree to which results can be parsed into separate domains of cognitive functioning. separate domains of cognitive functioning. The most appropriate depends on the The most appropriate depends on the setting and the question being addressed. setting and the question being addressed.
Conclusions Conclusions Cognitive outcome meas-
Cognitive outcome measures have reshaped our understanding of ures have reshaped our understanding of schizophrenia and will be essentialtools for schizophrenia and will be essentialtools for unravelling the aetiologyofthe disease and unravelling the aetiologyofthe disease and designing more effective interventions. designing more effective interventions.
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In an attempt to classify the multitude of In an attempt to classify the multitude of mental disorders he encountered in his mental disorders he encountered in his work, Emil Kraepelin adopted the term work, Emil Kraepelin adopted the term 'dementia praecox' to label a condition 'dementia praecox' to label a condition characterised by early psychosis and characterised by early psychosis and cognitive deterioration (Hoenig, 1983) . cognitive deterioration (Hoenig, 1983) . Although Bleuler renamed the disease Although Bleuler renamed the disease schizophrenia in 1911, emphasising his schizophrenia in 1911, emphasising his view of the disease as a lack of connection view of the disease as a lack of connection between a person's affect, thought and between a person's affect, thought and perception, he still viewed cognitive deficits perception, he still viewed cognitive deficits as integral to the disorder (Gabriele, 2000) . as integral to the disorder (Gabriele, 2000) . The perceived importance of cognition in The perceived importance of cognition in schizophrenia has since waxed and waned. schizophrenia has since waxed and waned. Cognitive and negative symptoms, which Cognitive and negative symptoms, which were regarded as integral by both Kraepelin were regarded as integral by both Kraepelin and Bleuler, were later overshadowed by and Bleuler, were later overshadowed by the more easily observable and identifiable the more easily observable and identifiable positive symptoms. The Research Diagnospositive symptoms. The Research Diagnostic Criteria (RDC), which were designed to tic Criteria (RDC), which were designed to formalise the diagnosis of mental disorders, formalise the diagnosis of mental disorders, emphasised the Schneiderian symptoms, emphasised the Schneiderian symptoms, and this tradition has continued into and this tradition has continued into DSM-III and IV DSM-III and IV (Andreasen, 1997) .
(Andreasen, 1997). Although negative symptoms were added Although negative symptoms were added as criteria in DSM-IV, cognition is still as criteria in DSM-IV, cognition is still not included in the formal criteria. not included in the formal criteria.
Although the move away from cognitive Although the move away from cognitive impairment as a focus in schizophrenia was impairment as a focus in schizophrenia was initially motivated by enhancement of diaginitially motivated by enhancement of diagnostic reliability, it came to shape how the disnostic reliability, it came to shape how the disease was viewed and investigated. However, a ease was viewed and investigated. However, a renewed interest in cognition has been evident renewed interest in cognition has been evident recently, spurred in part by the strong empirirecently, spurred in part by the strong empirical relationship between cognition and realcal relationship between cognition and realworld functioning (Green, 1996) . Several world functioning (Green, 1996) . Several studies have failed to demonstrate a signifistudies have failed to demonstrate a significant correlation between positive symptoms cant correlation between positive symptoms and functional outcome (Green, 1996) , sugand functional outcome (Green, 1996) , suggesting that a diagnostic and treatment focus gesting that a diagnostic and treatment focus on Schneiderian first-rank symptoms has on Schneiderian first-rank symptoms has sidelined key aspects of the disease. sidelined key aspects of the disease.
IMPAIRED COGNITION IMPAIRED COGNITION AS A CORE FEATURE AS A CORE FEATURE
A mounting body of evidence indicates that A mounting body of evidence indicates that diminished cognitive ability is a core feature diminished cognitive ability is a core feature of schizophrenia. Severely impaired perforof schizophrenia. Severely impaired performance on cognitive tests (two standard mance on cognitive tests (two standard deviations below the mean of healthy deviations below the mean of healthy controls) in several cognitive domains is controls) in several cognitive domains is strong evidence for the importance of cogstrong evidence for the importance of cognitive impairment in the disease (Saykin nitive impairment in the disease (Saykin et et al al, 1991; Harvey & Keefe, 1997 Although some studies have indicated Although some studies have indicated that a significant portion of people with that a significant portion of people with schizophrenia test in the normal cognitive schizophrenia test in the normal cognitive range (Palmer range (Palmer et al et al, 1997) , strong evidence , 1997), strong evidence suggests that even these exhibit cognitive suggests that even these exhibit cognitive abilities below those expected if they did abilities below those expected if they did not have the disease. A study of mononot have the disease. A study of monozygotic twins found that 80-95% of twins zygotic twins found that 80-95% of twins with schizophrenia scored below their unafwith schizophrenia scored below their unaffected twin (Goldberg fected twin (Goldberg et al et al, 1993) . Another , 1993). Another study found that 98% of people with study found that 98% of people with schizophrenia performed below the level schizophrenia performed below the level predicted by estimates of their premorbid predicted by estimates of their premorbid functioning based on level of parental functioning based on level of parental education, compared with 42% of controls education, compared with 42% of controls (Keefe (Keefe et al et al, 2005) . , 2005). Many early studies of the cognitive defMany early studies of the cognitive deficit in schizophrenia were of people who icit in schizophrenia were of people who were either taking antipsychotics at the were either taking antipsychotics at the time of the study or had taken them in the time of the study or had taken them in the past. However, several studies have since past. However, several studies have since demonstrated cognitive deficits in people demonstrated cognitive deficits in people with first-episode schizophrenia who have with first-episode schizophrenia who have never taken antipsychotics (Saykin never taken antipsychotics (Saykin et al et al, , 1994; Mohamed 1994; Mohamed et al et al, 1999; Bilder , 1999; Bilder et al et al, , 2000; Torrey, 2002 Torrey, ). 2000 Torrey, 2002) .
Unlike Schneiderian first-rank sympUnlike Schneiderian first-rank symptoms, cognitive deficits correlate highly with toms, cognitive deficits correlate highly with measures of functional outcome (Velligan measures of functional outcome (Velligan et al et al, 1997; Addington & Addington, , 1997; Addington & Addington, 1999; Green 1999; Green et al et al, 2000) . In addition, the , 2000). In addition, the literature overwhelmingly supports a literature overwhelmingly supports a longitudinal correlation between cognitive longitudinal correlation between cognitive ability at baseline and later assessments of ability at baseline and later assessments of functional outcome (Green functional outcome (Green et al et al, 2004; , 2004; Carlsson Carlsson et al et al, 2006) , suggesting that cogni-, 2006), suggesting that cognitive deficits are a key and perhaps limiting tive deficits are a key and perhaps limiting factor in rehabilitation of people with factor in rehabilitation of people with schizophrenia. The overwhelming evidence schizophrenia. The overwhelming evidence supporting neurocognitive deficits as a core supporting neurocognitive deficits as a core feature of schizophrenia and predictive of feature of schizophrenia and predictive of functional outcome has spurred the United functional outcome has spurred the United States National Institute of Mental Health States National Institute of Mental Health (NIMH) to target such deficits for (NIMH) to target such deficits for pharmacological intervention (Marder & pharmacological intervention (Marder & Fenton, 2004) . Fenton, 2004) .
SEPARATE DOMAINS SEPARATE DOMAINS OF DEFICIT OF DEFICIT V. V. GENER AL GENER AL DEFICIT DEFICIT
A crucial consideration for practical assess-A crucial consideration for practical assessment of cognition in schizophrenia centres ment of cognition in schizophrenia centres around whether the cognitive deficit is best around whether the cognitive deficit is best described as broad or is more pronounced described as broad or is more pronounced in specific domains. A large factor-analytical in specific domains. A large factor-analytical study involving the Wechsler Adult Intellistudy involving the Wechsler Adult Intelligence Scale (WAIS-III) and Wechsler Memgence Scale (WAIS-III) and Wechsler Memory Scale (WMS-III) batteries found that ory Scale (WMS-III) batteries found that the performance of 1250 healthy controls the performance of 1250 healthy controls was best described by a model composed was best described by a model composed of six separable domains of cognition: of six separable domains of cognition: verbal comprehension, perceptual organisaverbal comprehension, perceptual organisation, auditory memory, visual memory, tion, auditory memory, visual memory, working memory and processing speed working memory and processing speed (Tulsky & Price, 2003) . Although a meta- (Tulsky & Price, 2003) . Although a metaanalysis of 22 studies of cognitive perforanalysis of 22 studies of cognitive performance in populations with schizophrenia mance in populations with schizophrenia reported a strikingly broad deficit spanning reported a strikingly broad deficit spanning all domains (Heinrichs & Zakzanis, 1998) , all domains (Heinrichs & Zakzanis, 1998) , some theories have focused on specific some theories have focused on specific domains of impairment, such as working domains of impairment, such as working memory (Goldman-Rakic, 1994 ), verbal memory (Goldman-Rakic, 1994 , verbal memory (Saykin memory (Saykin et al et al, 1994) , and executive , 1994), and executive functions (Goldberg functions (Goldberg et al et al, 1987) . However, , 1987 
TOOLS FOR MEASURING TOOLS FOR MEASURING COGNITION COGNITION
A great many tasks have been developed to A great many tasks have been developed to assess cognition and various batteries comassess cognition and various batteries comprised of these tasks have been employed in prised of these tasks have been employed in research with populations with schizoresearch with populations with schizophrenia ( Table 1) . The most appropriate phrenia (Table 1 ). The most appropriate battery for a given study will depend upon battery for a given study will depend upon the questions being addressed, study setthe questions being addressed, study settings and available resources. A long battings and available resources. A long battery comprised of many different tests has tery comprised of many different tests has the disadvantage that missing data will be the disadvantage that missing data will be increased increased (Keefe (Keefe et al et al, 2004) . In addition, , 2004 ). In addition, attrition rates and missing data may be attrition rates and missing data may be higher in those with the most impairment, higher in those with the most impairment, thus skewing results. Also, in many settings thus skewing results. Also, in many settings extensive batteries are impractical because extensive batteries are impractical because of the time requirements placed on staff of the time requirements placed on staff members administering the tests. However, members administering the tests. However, a longer test battery usually will increase a longer test battery usually will increase the ability of the data to measure multiple the ability of the data to measure multiple domains of cognition. Thus if the research domains of cognition. Thus if the research question involves the efficacy of a treatquestion involves the efficacy of a treatment intervention for improving cognition, ment intervention for improving cognition, a composite score from a small battery a composite score from a small battery might be sufficient and allow for a larger might be sufficient and allow for a larger number of participants to complete the number of participants to complete the study while requiring fewer staff resources. study while requiring fewer staff resources. If, however, the research question involves If, however, the research question involves relative strengths and weaknesses of varrelative strengths and weaknesses of various cognitive domains, a thorough battery ious cognitive domains, a thorough battery composed of multiple tasks in each domain composed of multiple tasks in each domain may be required. If the research question is may be required. If the research question is primarily focused on one cognitive domain, primarily focused on one cognitive domain, a brief general battery in combination with a brief general battery in combination with s 4 7 s 4 7 AUTHOR'S PROOF AUTHOR'S PROOF , 1997b b) ) have long been the most widely employed have long been the most widely employed batteries of assessment for IQ and memory batteries of assessment for IQ and memory in healthy populations. However, the in healthy populations. However, the WAIS-III alone requires approximately WAIS-III alone requires approximately 100 min for completion in a mixed clinical 100 min for completion in a mixed clinical population (Ryan population (Ryan et al et al, 1998) . For studies , 1998). For studies of populations with schizophrenia, reof populations with schizophrenia, researchers using these batteries have tended searchers using these batteries have tended to reduce the number of sub-tests administo reduce the number of sub-tests administered to reduce demands on the patients tered to reduce demands on the patients and staff. Blyler and staff. Blyler et al et al (2000) used regression (2000) used regression analysis to determine the four tests covering analysis to determine the four tests covering all four domains of functioning assessed by all four domains of functioning assessed by the WAIS-III that would best account for the WAIS-III that would best account for the variance in full-scale IQ in a sample of the variance in full-scale IQ in a sample of 41 out-patients with schizophrenia. They 41 out-patients with schizophrenia. They found that a shortened version of the found that a shortened version of the WAIS-III, consisting of the sub-tests infor-WAIS-III, consisting of the sub-tests information, block design, arithmetic and digit mation, block design, arithmetic and digit symbol took only 30 min to administer symbol took only 30 min to administer and accounted for 90% of the variance in and accounted for 90% of the variance in the full-scale IQ of the schizophrenia the full-scale IQ of the schizophrenia patients. Because of its brevity, the shortpatients. Because of its brevity, the shortened version of the WAIS may have utility ened version of the WAIS may have utility as a routine measure of cognition in clinical as a routine measure of cognition in clinical practice. practice. . The MCCB is a relatively conEmotions). The MCCB is a relatively concise battery (taking just 65 min to admincise battery (taking just 65 min to administer) that none the less allows for ister) that none the less allows for measurement of cognition at a domainmeasurement of cognition at a domainspecific level. Because the final battery specific level. Because the final battery was co-normed with 300 community conwas co-normed with 300 community controls across five academic sites, an indivitrols across five academic sites, an individual's results can be normalised against dual's results can be normalised against this same control group for all seven dothis same control group for all seven domain scores as well as a composite score. main scores as well as a composite score. The MCCB has a computerised scoring sysThe MCCB has a computerised scoring system that produces tem that produces t t-scores and percentiles -scores and percentiles corrected for age and gender. Although corrected for age and gender. Although the MCCB was designed to assess effects the MCCB was designed to assess effects of pharmaceutical interventions on cogniof pharmaceutical interventions on cognition in schizophrenia, the battery is suitable tion in schizophrenia, the battery is suitable for use in cognitive remediation and nonfor use in cognitive remediation and nonintervention studies of people with schizointervention studies of people with schizophrenia. Although the MCCB requires phrenia. Although the MCCB requires more time to administer than the shortened more time to administer than the shortened WAIS-III, it has the potential to provide a WAIS-III, it has the potential to provide a more detailed assessment of a patient's more detailed assessment of a patient's cognitive performance. cognitive performance.
MATRICS Consensus Cognitive MATRICS Consensus Cognitive Battery Battery

Schizophrenia Cognition Rating Schizophrenia Cognition Rating Scale Scale
The Schizophrenia Cognition Rating Scale The Schizophrenia Cognition Rating Scale (SCoRS; Keefe (SCoRS; Keefe et al et al, 2006 Keefe et al et al, , 2006b is an 18-item ) is an 18-item interview-based assessment which covers interview-based assessment which covers all the cognitive domains tested in the all the cognitive domains tested in the MCCB, except social cognition, and takes MCCB, except social cognition, and takes approximately 12 min to complete. It is approximately 12 min to complete. It is administered separately to the patient and administered separately to the patient and to an informant (family member, friend, to an informant (family member, friend, social worker, etc.) The interviewee is social worker, etc.) The interviewee is asked to rate the patient's level of difficulty asked to rate the patient's level of difficulty in performing various cognitive functions in performing various cognitive functions on a 4-point scale, with 4 being the most on a 4-point scale, with 4 being the most difficulty and 1 being the least. Upon comdifficulty and 1 being the least. Upon completion of the 18 items, the interviewee is pletion of the 18 items, the interviewee is asked to give a global rating of the patient's asked to give a global rating of the patient's cognitive functioning on a scale of 1-10. cognitive functioning on a scale of 1-10. After the interview has been administered After the interview has been administered to both the patient and the informant, the to both the patient and the informant, the interviewer ranks the patient on all 18 items, interviewer ranks the patient on all 18 items, and gives a global score based on the reand gives a global score based on the responses of both the patient and informant sponses of both the patient and informant as well as the interviewer's observations of as well as the interviewer's observations of the patient. the patient. Step-wise regression analysis demon-1999).
Step-wise regression analysis demonstrated that the interviewer's global rating strated that the interviewer's global rating accounted for significant variance in realaccounted for significant variance in realworld functioning as measured by the ILSI world functioning as measured by the ILSI beyond that explained by results from the beyond that explained by results from the BACS and the UPSA (Keefe BACS and the UPSA (Keefe et al et al, 2006 (Keefe et al et al, , 2006b . ). Because the SCoRS assessment is based on Because the SCoRS assessment is based on patient and informant reports, it has high patient and informant reports, it has high face validity. face validity.
In addition to its utility as a coping In addition to its utility as a coping measure with the MCCB in drug trials, measure with the MCCB in drug trials, the SCoRS is ideally suited for use in the the SCoRS is ideally suited for use in the clinic and may thus increase awareness of clinic and may thus increase awareness of cognitive deficits in the diagnosis and treatcognitive deficits in the diagnosis and treatment of people with schizophrenia. Because ment of people with schizophrenia. Because patient scores have been found to account patient scores have been found to account for little variance in cognitive performance, for little variance in cognitive performance, functional capacity or real-world functionfunctional capacity or real-world functioning scores beyond that accounted for by ining scores beyond that accounted for by informant ratings (Keefe formant ratings (Keefe et al et al, 2006 (Keefe et al et al, , 2006b , it is ), it is possible that informant ratings alone could possible that informant ratings alone could be collected when an informant has suffibe collected when an informant has sufficient contact with the patient. The assesscient contact with the patient. The assessment time could then be limited to 15 ment time could then be limited to 15 min. In addition, the SCoRS should be a min. In addition, the SCoRS should be a familiar procedure for clinicians, who familiar procedure for clinicians, who should require significantly less training should require significantly less training than for batteries involving less familiar than for batteries involving less familiar cognitive testing procedures. Interrater cognitive testing procedures. Interrater reliability of the SCoRS should be estabreliability of the SCoRS should be established before it is used for clinical or lished before it is used for clinical or research purposes. research purposes.
UCSD Performance-Based Skills UCSD Performance-Based Skills Assessment Assessment
The University of California San Diego The University of California San Diego Performance-Based Skills Assessment Performance-Based Skills Assessment (UPSA) was developed as a proxy of real-(UPSA) was developed as a proxy of realworld functioning that is implemented in world functioning that is implemented in role-play. The UPSA measures daily living role-play. The UPSA measures daily living skills by recreating, in a clinical environskills by recreating, in a clinical environment, situations a patient is likely to enment, situations a patient is likely to encounter in the real world. The tasks fall counter in the real world. ). Initial assessment found that UPSA scores for peoassessment found that UPSA scores for people with schizophrenia and schizoaffective ple with schizophrenia and schizoaffective disorders correlated significantly with both disorders correlated significantly with both negative negative symptom severity and cognitive imsymptom severity and cognitive impairment, pairment, but not positive symptom severity but not positive symptom severity (Patterson (Patterson et al et al, 2001 ). Owing to the high , 2001). Owing to the high face validity imparted by the 'real-world' face validity imparted by the 'real-world' nature of the assessment, the MATRICS nature of the assessment, the MATRICS committee adopted the UPSA as a second committee adopted the UPSA as a second co-primary measure for studies of cognition co-primary measure for studies of cognition in schizophrenia. The high degree of face in schizophrenia. The high degree of face validity might increase the cooperation of validity might increase the cooperation of patients when it is used as a routine clinical patients when it is used as a routine clinical assessment. assessment.
Repeatable Battery Repeatable Battery for the Assessment for the Assessment of Neuropsychological Status of Neuropsychological Status
The Repeatable Battery for the Assessment The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS; of Neuropsychological Status (RBANS; Randolph, 1998) is a brief (45 min) assessRandolph, 1998) is a brief (45 min) assessment originally designed to test cognitive ment originally designed to test cognitive performance in older patients which has performance in older patients which has shown utility in providing reliable assessshown utility in providing reliable assessment of cognitive performance in populament of cognitive performance in populations with schizophrenia (Wilk tions with schizophrenia (Wilk et al et al, , 2002; Weber, 2003) . The performance of 2002; Weber, 2003) . The performance of people with schizophrenia on the RBANS people with schizophrenia on the RBANS is highly correlated with performance on is highly correlated with performance on the much longer WAIS-III and WMS-III the much longer WAIS-III and WMS-III batteries (Gold batteries (Gold et al et al, 1999; Hobart , 1999; Hobart et al et al, , 1999) . Because it was designed to be admin-1999). Because it was designed to be administered repeatedly, the RBANS does not istered repeatedly, the RBANS does not suffer from large practice effects. However, suffer from large practice effects. However, because the battery was developed to test because the battery was developed to test for dementia, it is comprised largely of tests for dementia, it is comprised largely of tests of memory, language and visual perception, of memory, language and visual perception, and may suffer from ceiling effects on some and may suffer from ceiling effects on some sub-tests when used in people with schizosub-tests when used in people with schizophrenia. The battery also lacks measures phrenia. The battery also lacks measures of motor, executive and working memory of motor, executive and working memory performance, cognitive domains thought performance, cognitive domains thought to be important in the cognitive impairment to be important in the cognitive impairment observed in schizophrenia. Despite these observed in schizophrenia. Despite these omissions, the RBANS is an appealing tool omissions, the RBANS is an appealing tool for the assessment of cognition in routine for the assessment of cognition in routine clinical practice owing to its relative clinical practice owing to its relative brevity. brevity.
Brief Assessment of Cognition Brief Assessment of Cognition in Schizophrenia in Schizophrenia
The Brief Assessment of Cognition in The Brief Assessment of Cognition in Schizophrenia (BACS; Keefe Schizophrenia (BACS; Keefe et al et al, 2004) , 2004) retains the positive attributes of the RBANS retains the positive attributes of the RBANS (brevity of administration and scoring, (brevity of administration and scoring, repeatability and portability) and more repeatability and portability) and more completely assesses the extent of cognitive completely assesses the extent of cognitive impairment over multiple domains thought impairment over multiple domains thought to be affected by schizophrenia (Table 2) . to be affected by schizophrenia (Table 2) . The BACS, available in nine languages, The BACS, available in nine languages, requires approximately 30 min to complete requires approximately 30 min to complete and is devised for easy administration and and is devised for easy administration and scoring. The battery is specifically designed scoring. The battery is specifically designed to measure treatment-related changes in to measure treatment-related changes in cognition, and has alternate forms, thus cognition, and has alternate forms, thus minimising practice effects. The battery minimising practice effects. The battery includes brief assessments of executive includes brief assessments of executive functions, verbal fluency, attention, verbal functions, verbal fluency, attention, verbal memory, working memory and motor memory, working memory and motor speed, and generates a composite score that speed, and generates a composite score that is calculated by summing is calculated by summing z z-scores derived -scores derived by comparisons with a normative sample by comparisons with a normative sample of 400 healthy controls. Its reliability, vaof 400 healthy controls. Its reliability, validity and comparability of forms has been lidity and comparability of forms has been established empirically (Keefe established empirically (Keefe et al et al, 2004) . , 2004). The composite score has high test-retest reThe composite score has high test-retest reliability in people with schizophrenia and liability in people with schizophrenia and healthy controls (intraclass correlation healthy controls (intraclass correlation coefficients coefficients4 40.80). The BACS composite 0.80). The BACS composite score has been shown to be as sensitive to score has been shown to be as sensitive to the cognitive deficits of schizophrenia as a the cognitive deficits of schizophrenia as a standard 2.5-hour battery (Keefe standard 2.5-hour battery (Keefe et al et al, , 2004 ) and is highly correlated ( 2004) and is highly correlated (r r¼0.84, 0.84, P P5 50.001) with the composite score derived 0.001) with the composite score derived from the CATIE neurocognitive test battery from the CATIE neurocognitive test battery (Keefe (Keefe et al et al, 2007) . The BACS also has clear , 2007). The BACS also has clear functional relevance, as the composite score functional relevance, as the composite score is strongly related to functional measures is strongly related to functional measures such as independent living skills ( such as independent living skills (r r¼0.45), 0.45), performance-based assessment of functionperformance-based assessment of functioning ( ing (r r¼0.56) and interview-based assess-0.56) and interview-based assessments of cognition in people with ments of cognition in people with schizophrenia ( schizophrenia (r r¼0.48) (Keefe 0.48) (Keefe et al et al, , 2006 (Keefe et al et al, , 2006c . The BACS is well suited to routine ). The BACS is well suited to routine clinical administration when a quick assessclinical administration when a quick assessment of overall cognitive functioning is ment of overall cognitive functioning is required. required.
Brief Cognitive Assessment Brief Cognitive Assessment
An even shorter battery is the Brief CogniAn even shorter battery is the Brief Cognitive Assessment (BCA; Velligan tive Assessment (BCA; Velligan et al et al, , 2004) , which was designed to assess cogni-2004), which was designed to assess cognition in people with schizophrenia in 15 tion in people with schizophrenia in 15 min. Initial assessment of the battery has min. Initial assessment of the battery has indicated good test-retest reliability and indicated good test-retest reliability and strong correlation ( strong correlation (r r¼0.72; 0.72; P P5 50.0001) 0.0001) with an extensive 2-hour battery (Velligan with an extensive 2-hour battery (Velligan et al et al, 2004) . The two batteries showed simi-, 2004). The two batteries showed similar correlations with measures of functional lar correlations with measures of functional ability. Normative data are available allowability. Normative data are available allowing adjustments for practice effects when ing adjustments for practice effects when performing repeated assessments. The performing repeated assessments. The extreme brevity of the BCA makes it a extreme brevity of the BCA makes it a strong candidate for routine clinical strong candidate for routine clinical administration. administration.
Computerised batteries Computerised batteries
A recent development in cognitive assess-A recent development in cognitive assessment for clinical trials is the availability of ment for clinical trials is the availability of computerised test batteries that allow direct computerised test batteries that allow direct data transfer to study databases. These data transfer to study databases. These methods minimise rater error and reduce methods minimise rater error and reduce the costs for human quality assurance. the costs for human quality assurance. However, many of these methods have However, many of these methods have not been fully validated and therefore not been fully validated and therefore results must be evaluated carefully. results must be evaluated carefully.
PSYCHOPHYSIOLOGICAL PSYCHOPHYSIOLOGICAL TASKS TASKS
Assessment of psychophysiological tasks is Assessment of psychophysiological tasks is appealing because much of the underlying appealing because much of the underlying neurobiological circuitry has been uncovneurobiological circuitry has been uncovered in animal and human studies. Howered in animal and human studies. However, care must be taken when inferring ever, care must be taken when inferring an aetiological basis or treatment strategy an aetiological basis or treatment strategy for schizophrenia from the performance of for schizophrenia from the performance of patients on these tasks. The outstanding patients on these tasks. The outstanding s 4 9 s 4 9 AUTHOR'S PROOF AUTHOR'S PROOF question remains whether interventions question remains whether interventions that improve the performance of patients that improve the performance of patients on these tasks would have any effect on on these tasks would have any effect on the whole of cognition or on functional outthe whole of cognition or on functional outcomes. Regardless of their utility in uncomes. Regardless of their utility in uncovering neurobiological underpinnings of covering neurobiological underpinnings of the disease, psychophysiological tasks are the disease, psychophysiological tasks are particularly appealing for use in genetic particularly appealing for use in genetic studies as tools to quickly assess an studies as tools to quickly assess an endophenotype that might reflect a specific endophenotype that might reflect a specific genotypic vulnerability to schizophrenia. genotypic vulnerability to schizophrenia. Some of the most utilised psychophysiologiSome of the most utilised psychophysiological tasks are briefly described below. cal tasks are briefly described below.
Eye movements Eye movements
Several eye movement abnormalities have Several eye movement abnormalities have been associated with schizophrenia. Two been associated with schizophrenia. Two of the most prominent are abnormalities of the most prominent are abnormalities in smooth-pursuit eye movements, in which in smooth-pursuit eye movements, in which the patient is instructed to maintain foveathe patient is instructed to maintain foveation of a smoothly moving target, and antition of a smoothly moving target, and antisaccade performance, in which the patient saccade performance, in which the patient is instructed to make a mirror image is instructed to make a mirror image saccade away from a suddenly appearing saccade away from a suddenly appearing visual cue. visual cue.
Antisaccade Antisaccade
Lesion studies in non-human primates have Lesion studies in non-human primates have demonstrated the importance of the dorsodemonstrated the importance of the dorsolateral prefrontal cortex for inhibiting lateral prefrontal cortex for inhibiting reflexive prosaccades in the antisaccade reflexive prosaccades in the antisaccade paradigm (Fukushima paradigm (Fukushima et al et al, 1994) . Like-, 1994) . Likewise, converging evidence has suggested wise, converging evidence has suggested that the dorsolateral prefrontal cortex is that the dorsolateral prefrontal cortex is compromised in people with schizophrenia compromised in people with schizophrenia (Bunney & Bunney, 2000) . A review of (Bunney & Bunney, 2000) . A review of patients' performance on the antisaccade patients' performance on the antisaccade task strongly indicates a significant elevatask strongly indicates a significant elevation in erroneous prosaccades that is stable tion in erroneous prosaccades that is stable over time (Everling & Fischer, 1998) . This over time (Everling & Fischer, 1998) . This was recently replicated in a seven site study was recently replicated in a seven site study by the Consortium on the Genetics of by the Consortium on the Genetics of Schizophrenia in which the antisaccade perSchizophrenia in which the antisaccade performance of 143 people with schizophrenia formance of 143 people with schizophrenia was compared with that of 195 controls was compared with that of 195 controls (Radant (Radant et al et al, 2007) . All sites found a sig-, 2007). All sites found a significant difference in the number of errors nificant difference in the number of errors (reflexive prosaccades) made by the two (reflexive prosaccades) made by the two groups. In addition, first-degree relatives groups. In addition, first-degree relatives of people with schizophrenia have demonof people with schizophrenia have demonstrated higher reflexive saccade rates than strated higher reflexive saccade rates than unrelated controls (Clementz unrelated controls (Clementz et al et al, 1994 (Clementz et al et al, ), , 1994 , suggesting that the endophenotype reflects suggesting that the endophenotype reflects a genetic vulnerability to schizophrenia. a genetic vulnerability to schizophrenia.
Smooth-pursuit eye tracking Smooth-pursuit eye tracking
Decreased pursuit gain has long been Decreased pursuit gain has long been viewed as a characteristic impairment in viewed as a characteristic impairment in people with schizophrenia. However, it people with schizophrenia. However, it was recently shown that people with affecwas recently shown that people with affective disorder displayed an indistinguishable tive disorder displayed an indistinguishable smooth-pursuit gain (Kathmann smooth-pursuit gain (Kathmann et al et al, , 2003) . Likewise, unaffected relatives of 2003). Likewise, unaffected relatives of the two groups did not differ in their purthe two groups did not differ in their pursuit gain deficiencies. These results argue suit gain deficiencies. These results argue against the utility of smooth-pursuit gain against the utility of smooth-pursuit gain as a phenotypic marker reflecting a as a phenotypic marker reflecting a genotype specific to schizophrenia. Howgenotype specific to schizophrenia. However, high rates of catch-up saccades ever, high rates of catch-up saccades (Sweeney (Sweeney et al et al, 1994) and anticipatory sac-, 1994) and anticipatory saccades (Rosenberg cades (Rosenberg et al et al, 1997) in the , 1997) in the smooth-pursuit paradigm appear to be smooth-pursuit paradigm appear to be specific to schizophrenia and may offer specific to schizophrenia and may offer phenotypic measures for genetic studies. phenotypic measures for genetic studies.
Prepulse inhibition and P50 Prepulse inhibition and P50
Prepulse inhibition and P50 are both Prepulse inhibition and P50 are both measures of pre-attentive processing that measures of pre-attentive processing that display impairment in people with schizodisplay impairment in people with schizophrenia and have been thoroughly rephrenia and have been thoroughly researched in animal models. However, searched in animal models. However, impairment in both of these paradigms is impairment in both of these paradigms is fairly widespread over various psychiatric fairly widespread over various psychiatric populations, thus decreasing the utility of populations, thus decreasing the utility of these measures as an endophenotype for these measures as an endophenotype for schizophrenia (Bart, 2004) schizophrenia (Bart, 2004) 
CONCLUSIONS CONCLUSIONS
Cognitive impairment is returning to proCognitive impairment is returning to prominence in the conceptualisation and pracminence in the conceptualisation and practical assessment of schizophrenia, and is tical assessment of schizophrenia, and is being considered for inclusion in the ICD being considered for inclusion in the ICD and DSM diagnostic criteria. A wide variand DSM diagnostic criteria. A wide variety of batteries currently exist for assessing ety of batteries currently exist for assessing cognitive impairment in relation to the discognitive impairment in relation to the disease, and cognitive outcome measures are ease, and cognitive outcome measures are essential as the field moves forward. Howessential as the field moves forward. However, current options are lacking in several ever, current options are lacking in several regards. Notably, most cognitive outcome regards. Notably, most cognitive outcome measures tend to suffer from low face measures tend to suffer from low face validity: it is not obvious to patients or validity: it is not obvious to patients or caregivers that improvements in perforcaregivers that improvements in performance on these batteries would make a mance on these batteries would make a difference to the patient's quality of life. difference to the patient's quality of life. Therefore, it is essential in many circumTherefore, it is essential in many circumstances that an appropriate test of funcstances that an appropriate test of functional outcome is co-administered with a tional outcome is co-administered with a cognitive battery. Interview-based measures cognitive battery. Interview-based measures and functional proxy measures are based and functional proxy measures are based upon measures of intuitive value to patients upon measures of intuitive value to patients and clinicians, and are amenable to use in and clinicians, and are amenable to use in the clinic, where cognitive assessments are the clinic, where cognitive assessments are far from routine because of the onerous far from routine because of the onerous nature of administering most batteries. nature of administering most batteries. Also, although modern cognitive batteries Also, although modern cognitive batteries strive to include tasks with low practice strive to include tasks with low practice effects, this confound is substantial. Thus, effects, this confound is substantial. Thus, trials involving repeated assessments of trials involving repeated assessments of patients require comparison with comparpatients require comparison with comparable control groups that have experienced able control groups that have experienced the same testing procedure. Another conthe same testing procedure. Another consideration in the choice of cognitive testing sideration in the choice of cognitive testing batteries is that differential sensitivity to batteries is that differential sensitivity to between-group or over-time differences between-group or over-time differences across individual tasks can cause spurious across individual tasks can cause spurious findings of differential impairment across findings of differential impairment across domains of cognitive functioning. The pardomains of cognitive functioning. The parsing of cognitive functioning into various sing of cognitive functioning into various domains is weakened by the lack of domain domains is weakened by the lack of domain specificity for many cognitive tests (Keefe, specificity for many cognitive tests (Keefe, 1995) . Despite these shortcomings, cogni-1995). Despite these shortcomings, cognitive outcome measures have reshaped our tive outcome measures have reshaped our view of schizophrenia and will be essential view of schizophrenia and will be essential for identifying its aetiology as well as for identifying its aetiology as well as designing more effective interventions. designing more effective interventions. 
